Owner La Jolla Pharmaceutical Company

Inventors Not Given

Agent FB Rice

Pub. Number AU-A-2004201699

Parent 43395

Filing date 19 April 2004

Wipo publication date 6 January 2005

C07K 014/47 Peptides having more than 20 amino acids

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 039/385 Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 038/17 Medicinal preparations containing peptides - from animals

A61P 037/00 Drugs for immunological or allergic disorders

G01N 033/92 Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 033/564 Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

C07K 014/775 Peptides having more than 20 amino acids

C07K 014/47 Peptides having more than 20 amino acids

C07K 017/06 Carrier-bound or immobilised peptides

C07K 019/00 Hybrid peptides

G01N 033/86 Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

C07K 007/08 Peptides having 5 to 20 amino acids in a fully defined sequence

G01N 033/564 Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence